Drugmakers Hold Back Swiss Reimbursement Applications Amid Pricing Concerns

Pharmaceutical companies are increasingly delaying applications for health-insurance reimbursement for new medicines in Switzerland, raising concerns about patient access to innovative treatments. A survey by Swiss pharmaceutical industry association Interpharma found that seven of 22 innovative medicines introduced between January 2025 and June 2026 were not submitted for inclusion on Switzerland’s mandatory health-insurance reimbursement list. […]

Continue Reading

Roche

Company Profile About Roche Roche is a global healthcare company combining pharmaceutical medicines, diagnostics and digital healthcare solutions. The company was founded in Basel, Switzerland, in 1896 by Fritz Hoffmann-La Roche and has developed into one of the world’s leading biotechnology and healthcare organizations. Roche’s pharmaceutical activities focus on developing innovative treatments across major disease […]

Continue Reading

Novartis

Company Profile About Novartis Novartis is a global innovative medicines company headquartered in Basel, Switzerland. The company was established in 1996 through the merger of Ciba-Geigy and Sandoz, creating one of the world’s major research-based pharmaceutical organizations. Novartis focuses on discovering and developing medicines intended to address significant disease burdens. Its principal research and therapeutic […]

Continue Reading